We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BID
8751
DELISTED
Sotheby's
BID
-744,823
Closed -$42.4M
PNTR
8752
DELISTED
Pointer Telocation Ltd.
PNTR
-1,410
Closed -$21K
EGI
8753
DELISTED
Entre Resources Ltd. Common Shares
EGI
-65,015
Closed -$12K
DTV
8754
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
-6,794
Closed -$394K
IGLD
8755
DELISTED
Internet Gold-Golden Lines Ltd
IGLD
-212
Closed -$4K
GNCA
8756
DELISTED
Genocea Biosciences, Inc.
GNCA
-2,954
Closed -$9K
NAVB
8757
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$0 ﹤0.01%
5
-4,676
-100% -$4.04K
DHXM
8758
DELISTED
DHX Media Ltd. Common Voting and Variable Voting Shares
DHXM
-1,035,500
Closed -$1.51M
SLNOW
8759
DELISTED
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
-5,523
Closed
DRYS
8760
DELISTED
DryShips Inc. Common Stock
DRYS
-60,660
Closed -$317K
OSN
8761
DELISTED
Ossen Innovation Co., Ltd.
OSN
-4,588
Closed -$17K
FRAK
8762
DELISTED
VanEck Vectors Unconventional Oil & Gas ETF
FRAK
-440
Closed -$46K
EMAG
8763
DELISTED
VanEck Vectors Emerging Markets Aggregate Bond ETF
EMAG
-93
Closed -$2K
RVLT
8764
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
-33,505
Closed -$7K
NYNY
8765
DELISTED
Empire Resorts, Inc.
NYNY
-4,661
Closed -$45K
CPAH
8766
DELISTED
Counterpath Corp
CPAH
-3,696
Closed -$4K
CID
8767
DELISTED
VictoryShares International High Div Volatility Wtd ETF
CID
-200
Closed -$6K
OHAI
8768
DELISTED
OHA Investment Corporation
OHAI
-383
Closed
TVIX
8769
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
-440
Closed -$60K
CELGZ
8770
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
-6,604
Closed -$4K
HPJ
8771
DELISTED
Highpower International Inc
HPJ
-1,959
Closed -$9K
VIA
8772
DELISTED
Viacom Inc. Class A
VIA
-37,745
Closed -$992K
KIQ
8773
DELISTED
Kelso Technologies Inc.
KIQ
-1,919
Closed -$1K
CHII
8774
DELISTED
Global X MSCI China Industrials ETF
CHII
$0 ﹤0.01%
2
-214
-99% -$2.77K
BKSC
8775
DELISTED
Bank of South Carolina
BKSC
-225
Closed -$4K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.